Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oklo Inc.CL A(OKLO) | 0 | 6,920,804 | +6,920,804 | $0 | $58.62M | 41.08% | +$58.62M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 5,941,120 | 5,941,120 | 0 | $59.23M | $44.56M | 31.23% | -$14.67M |
| Evolv Technologies Holdings, Inc.CL A(EVLV) | 9,681,281 | 9,681,281 | 0 | $43.08M | $24.69M | 17.30% | -$18.39M |
| Rocket Lab USA, Inc. | 2,929,350 | 2,929,350 | 0 | $12.04M | $14.06M | 9.85% | +$2.02M |
| Mind Medicine (MindMed) Inc. | 100,350 | 100,350 | 0 | $943.3K | $723.5K | 0.51% | -$219.8K |
| Roivant Sciences Ltd.SHS(ROIV) | 3,875 | 3,875 | 0 | $40.8K | $41.0K | 0.03% | +$116 |